Cited by 21Social Media in Health EducationHealth Literacy and Information AccessibilityNeurogenetic and Muscular Disorders Research

Patient and family social media use surrounding a novel treatment for a rare genetic disease: a qualitative interview study

Open access
Iyer, Alexander A., Barzilay, Julie R., Tabor, Holly K.·2020·Genetics in Medicine

Abstract

Purpose Advances in gene therapy and precision medicine have led to a growing number of novel treatments for rare genetic diseases. Patients/families may lack access to up-to-date, accurate, and relevant information about these treatments. Social media offers one potentially important resource for these communities. Our goal was to understand how patients/families with spinal muscular atrophy (SMA)-a rare genetic condition-used social media to share, consume, and evaluate information about the novel treatment nusinersen (Spinraza) following the drug's approval. Methods We conducted qualitative, semistructured interviews with 20 SMA patients or parents of patients, deriving themes and subthemes through content and thematic network analysis. Participants also completed a demographic survey. Results Participants described leveraging social media to learn about nusinersen treatment, make informed treatment decisions, and advocate for/access treatment. They also described critically evaluating the trustworthiness of nusinersen-related information on social media and the privacy risks of social media use. Conclusion Patients/families used social media to navigate the new and dynamic landscape of nusinersen treatment for SMA, while attempting to mitigate misinformation and privacy risks. As new treatments become available, providers and patients/families may benefit from proactively discussing social media use, so as to maximize important benefits while minimizing risks.

Integrity signals

Registry

Crossref · 10.1038/s41436-020-0890-6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Iyer, A. A., Barzilay, J. R., & Tabor, H. K.
Affiliations
  • National Institutes of Health (US)
  • Stanford Medicine (US)
Corresponding author
Tabor, Holly K.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2020-11
Volume
22
Issue
11
Pages
1830-1837
ISSN
1098-3600 (ISSN-L)
OpenAlex
W3037947732
Cited by
21
References
5
Citations by year
2026: 2 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 3
FWCI
1.25
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Health › Social Media in Health Education
  • Health Sciences › Health Professions › General Health Professions › Health Literacy and Information Accessibility
  • Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
Keywords
social media use, spinal muscular atrophy, nusinersen, Spinraza, rare genetic disorders, patient information seeking, treatment decision-making, health misinformation, privacy risks, patient advocacy, trust in online health information, gene therapy
MeSH terms
Humans, Muscular Atrophy, Spinal, Parents, Rare Diseases, Qualitative Research, Social Media

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review